Dr Sophia Frentzas is a medical oncologist and clinical researcher focusing on gynaecological and gastrointestinal malignancies as well as Phase I clinical trials. Dr Frentzas graduated from Imperial College School of Medicine, London, in 2002. She has also completed a laboratory-based, translational PhD at the Institute of Cancer Research, University of London and was awarded her doctorate certificate in 2014. Since migrating to Australia in 2016, Dr Frentzas has worked as a Full Time Specialist in Medical Oncology at the Alan Walker Cancer Centre, Royal Darwin Hospital, NT. During this time, she chaired the Clinical Trials Unit at the Alan Walker Cancer Centre, was a member of the NT Cancer Care Network, was involved in outreach oncology clinic support in the Northern Territory, conducted the Cultural Awareness and Safety course, and participated in The Flinders University medical student teaching program. Dr Frentzas is now part of the medical oncology team at Monash Health where she specialises in the treatment of patients with colorectal, upper gastrointestinal tract, and gynaecological tract cancers. Her main research interests are focused on novel and personal approaches for the treatment of solid tumours, particularly in targeting aberrant pathways for angiogenesis, and on the investigation of strategies to overcome resistance to conventionally employed therapeutic agents. Her research has been published in a number of peer-reviewed, high impact factor journals, and abstracts. She has also had the opportunity to present her work at several national and international conferences.